GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...
Multiplex polymerase chain reaction (PCR) test has demonstrated its superiority in diagnosing gastrointestinal infections and has proved to be a rapid, sensitive and specific alternative to ...
Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital ...
Washington, DC – Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40 ...
Please provide your email address to receive an email when new articles are posted on . Jordan E. Axelrad, MD, MPH, of the Inflammatory Bowel Disease Center at NYU Langone Health, and colleagues wrote ...
Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...
Molecular test reportedly simultaneously detects and identifies 15 pathogens, delivering results in five hours. Luminex’ xTAG Gastrointestinal Pathogen Panel (GPP) has been granted a CE mark in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results